Scientists showed that Linezolid, a ribosomal-targeting antibiotic (RAbo), effectively blocked the course of a T cell-mediated autoimmune disease.
6445218 RJPP6HS8 items 1 apa default asc 1
Almeida, L., Dhillon-LaBrooy, A., Castro, C. N., Adossa, N., Carriche, G. M., Guderian, M., Lippens, S., Dennerlein, S., Hesse, C., Lambrecht, B. N., Berod, L., Schauser, L., Blazar, B. R., Kalesse, M., Müller, R., Moita, L. F., & Sparwasser, T. (2020). Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis. Immunity, 0(0). https://doi.org/10.1016/j.immuni.2020.11.001 Cite
Researchers describe a novel function of tumor-associated myeloid cells related to the enhanced breakdown of extracellular hyaluronan (HA) in human bladder cancer tissue, leading to the accumulation of small HA fragments with MW <20 kDa.
6445218 TU6BX4JG items 1 apa default asc 1
Scientists discovered that hepatic B cell lymphopoiesis did not cease after birth and that tolerance defects contributed to immunoglobulin G-autoantibody accumulation in biliary atresia.
6445218 25R6BVKI items 1 apa default asc 1
Wang, J., Xu, Y., Chen, Z., Liang, J., Lin, Z., Liang, H., Xu, Y., Wu, Q., Guo, X., Nie, J., Lu, B., Huang, B., Xian, H., Wang, X., Wu, Q., Zeng, J., Chai, C., Zhang, M., Lin, Y., … Zhang, Y. (2020). Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia. Cell, 0(0). https://doi.org/10.1016/j.cell.2020.10.048 Cite
Scientists discuss the roles of immunomodulatory receptors in the control of immunity from a perspective focused on therapeutic potential in not only cancer but also autoimmune diseases.
[Cellular & Molecular Immunology]
6445218 LYEHFCXP items 1 apa default asc 1
The liver is an immunologic organ with large populations of innate and innate-like immune cells and is exposed to bacterial, viral, and fungal antigens through the gut–liver axis. Scientists summarize and highlight the role of these cells in liver cancer and propose strategies to therapeutically target them.
[Cellular & Molecular Immunology]
Gain Therapeutics, Inc. announced a research collaboration with the University of Maryland School of Medicine (UMSOM), to investigate Gain’s structurally targeted allosteric regulators (STARs) in cellular models of neuronopathic Gaucher disease and Parkinson’s disease. STARs are proprietary small molecules targeting novel allosteric binding sites on enzymes.
[Gain Therapeutics, Inc. (Globe Newswire, Inc.)]
6445218 nan items 1 apa default asc 1
Local injections of myeloid cell-targeted STAT3 antisense oligonucleotide activated human DCs/macrophages, promoted CD8 T-cell recruitment and thereby arrested UM-SCC1 tumor growth.
[Journal of Clinical Investigation]
6445218 ZAXGTAY7 items 1 apa default asc 1
Moreira, D., Sampath, S., Won, H., White, S. V., Su, Y.-L., Alcantara, M., Wang, C., Lee, P. P., Maghami, E., Massarelli, E., & Kortylewski, M. (2020). Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI137001 Cite
Scientists conducted two clinical trials to verify the safety and efficacy of GC027, an “off-the-shelf” allogeneic CAR-T product targeting T cell antigen CD7. Here we report two patients as case reports with relapsed/refractory T-ALL who were treated with GC027.
[Clinical Cancer Research]
6445218 DGCMM9JJ items 1 apa default asc 1
Li, S., Wang, X., Yuan, Z., Liu, L., Luo, L., Li, Y., Wu, K., Liu, J., Yang, C., Li, Z., Wang, D., Shen, L., Ye, X., He, J., Han, C., Wang, Y., Zhang, D., Dong, Y., Fang, L., … Wang, S. (2020). Eradication of T-ALL cells by CD7 targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-20-1271 Cite
Thirteen B-cell acute lymphoblastic leukemia patients with relapsed after allo-hematopoietic stem cell transplantation and thus were treated with donor-derived anti-CD19 CAR T-cell.
[Bone Marrow Transplantation]
6445218 76ZS3GSV items 1 apa default asc 1
Hua, J., Zhang, J., Zhang, X., Wu, X., Zhou, L., Bao, X., Han, Y., Miao, M., Li, C., Fu, C., Chen, S., Tang, X., Wu, D., & Qiu, H. (2020). Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 1–9. https://doi.org/10.1038/s41409-020-01140-6 Cite
Researchers explored the effect of chemotherapy on CD4+ and CD8+ cells in the bronchoalveolar lavage fluid of the healthy lung in patients treated with standard chemotherapy regimens.
6445218 5ZYMXEAX items 1 apa default asc 1
Karpathiou, G., Mihailidis, V., Nakou, E., Anevlavis, S., Tzouvelekis, A., Kouliatsis, G., Ntolios, P., Bouros, D., Kotsianidis, I., & Froudarakis, M. E. (2020). Chemotherapy-induced changes in bronchoalveolar lavage fluid CD4 + and CD8 + cells of the opposite lung to the cancer. Scientific Reports, 10(1), 19927. https://doi.org/10.1038/s41598-020-76752-5 Cite
Investigators proposed a strategy to incorporate RvD1 and an antibiotic in human neutrophil-membrane derived nanovesicles that could specifically target inflamed vasculature for treatment of lung infection caused by P. aeruginosa.
6445218 RMAJPGMT items 1 apa default asc 1